Title: David A Morton - Innovator in Respiratory Disease Treatment
Introduction
David A Morton is a notable inventor based in Great Britain, recognized for his contributions to the field of respiratory disease treatment. His innovative approach focuses on pharmaceutical compositions that enhance pulmonary delivery systems.
Latest Patents
David A Morton holds a patent titled "The Treatment Of Respiratory Diseases." This patent describes a pharmaceutical composition for pulmonary delivery that comprises glycopyrrolate in a controlled release formulation. The formulation is designed to exert its pharmacological effect over a period greater than 12 hours upon administration.
Career Highlights
Morton is associated with Arakis Ltd., a company that specializes in developing innovative pharmaceutical solutions. His work at Arakis Ltd. has been instrumental in advancing treatments for respiratory conditions.
Collaborations
Some of his notable coworkers include Robin Mark Bannister and Andrew John Richards, who have collaborated with him on various projects within the pharmaceutical field.
Conclusion
David A Morton is a significant figure in the development of treatments for respiratory diseases, with a focus on innovative pharmaceutical compositions. His work continues to impact the field positively.